Genetic Analysis of MECP2 Gene in Iranian Patients with Rett Syndrome

Jafar Nasiri, Mansoor Salehi, Majid Hosseinzadeh, Mahdi Zamani, Shirin Fattahpour, Omid Aryani, Esmat Fazel-Najafabadi, Maryam Jabarzareh, Sara Asadi, Tahereh Gholamrezapour, Maryam Sedghi, Fatemeh Ghorbani





Rett syndrome is an X linked dominant neurodevelopmental disorder which almost exclusively affects females. The syndrome is usually caused by mutations in MECP2 gene, which is a nuclear protein that selectively binds CpG dinucleotides in the genome.

Materials & MethodsTo provide further insights into the distribution of mutations in MECP2 gene, we investigated 24 females with clinical characters of Rett syndrome referred to Alzahra University Hospital in Isfahan, Iran during 2015-2017. We sequenced the entire MECP2 coding region and splice sites for detection of point mutations in this gene. Freely available programs including JALVIEW, SIFT, and PolyPhen were used to find out the damaging effects of unknown mutations.ResultsDirect sequencing revealed MECP2 mutations in 13 of the 24 patients. We identified in 13 patients, 10 different mutations in MECP2 gene. Three of these mutations have not been reported elsewhere and are most likely pathogenic.ConclusionDefects in MECP2 gene play an important role in pathogenesis of Rett syndrome. Mutations in MECP2 gene can be found in the majority of Iranian RTT patients. We failed to identify mutations in MECP2 gene in 46% of our patients. For these patients, further molecular analysis might be necessary.


Rett syndrome; MECP1 mutation; direct sequencing; Iran

Full Text:




Psoni S, Sofocleous C, Traeger-Synodinos J, Kitsiou-Tzeli S, Kanavakis E, Fryssira-Kanioura H. Phenotypic and genotypic variability in four males with MECP2 gene sequence aberrations including a novel deletion. Pediatric research. 2010;67(5):551-6.

Gill H, Cheadle JP, Maynard J, Fleming N, Whatley S, Cranston T, et al. Mutation analysis in the MECP2 gene and genetic counselling for Rett syndrome. Journal of medical genetics. 2003;40(5):380-4.

Amir R, Fang P, Yu Z, Glaze D, Percy A, Zoghbi H, et al. Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. Journal of medical genetics. 2005;42(2):e15-e.

Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature genetics. 1999;23(2):185-8.

Liyanage VR, Rastegar M. Rett syndrome and MeCP2. Neuromolecular medicine. 2014;16(2):231-64.

Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome: comments to Rett syndrome clinical criteria consensus panel satellite to European Paediatric Neurology Society Meeting Baden Baden, Germany, 11 September 2001. European Journal of Paediatric Neurology. 2002;6(5):293-7.

Mabin D. Diagnostic criteria for Rett syndrome. The Rett Syndrome diagnostic criteria work groupAnn. Neurol231988425428. Neurophysiologie Clinique/Clinical Neurophysiology. 1988;18(6):574-5.

Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research. 1988;16(3):1215.

Obata K, Matsuishi T, Yamashita Y, Fukuda T, Kuwajima K, Horiuchi I, et al. Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome. Journal of medical genetics. 2000;37(8):608-10.

Lee SSJ, Wan M, Francke U. Spectrum of MECP2 mutations in Rett syndrome. Brain and Development. 2001;23:S138-S43.

Wan M, Lee SSJ, Zhang X, Houwink-Manville I, Song H-R, Amir RE, et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. The American Journal of Human Genetics. 1999;65(6):1520-9.

Shahbazian MD, Zoghbi HY. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Current opinion in neurology. 2001;14(2):171-6.

Fendri-Kriaa N, Hsairi I, Kifagi C, Ellouze E, Mkaouar-Rebai E, Triki C, et al. A case of a Tunisian Rett patient with a novel double-mutation of the MECP2 gene. Biochemical and biophysical research communications. 2011;409(2):270-4.

Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nature neuroscience. 2013;16(7):898-902.

Philippe C, Villard L, De Roux N, Raynaud M, Bonnefond J, Pasquier L, et al. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. European journal of medical genetics. 2006;49(1):9-18.

Bienvenu T, Carrié A, de Roux N, Vinet M-C, Jonveaux P, Couvert P, et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Human Molecular Genetics. 2000;9(9):1377-84.

Bzduch V, Zahorakova D, Grechanina E, Zdibskaja E, Goldfarb I, Zeman J, et al. A case of Rett syndrome from Ukraine-clinical diagnosis confirmed by mutation analysis of the MECP2 gene. Bratislavské lekárske listy. 2004;105(9):299-302.

Ghofrani M, Mahmoodian T. Rett syndrome. The Indian Journal of Pediatrics. 2000;67(7):539-40.

Noruzinia M, Akbari M, Ghofrani M, Sheikhha H. Rett syndrome molecular diagnosis and implications in genetic counseling. Indian journal of human genetics. 2007;13(3):119.

Gharesouran J, Khalili AF, Azari NS, Vahedi L. First case report of Rett syndrome in the Azeri Turkish population and brief review of the literature. Epilepsy & behavior case reports. 2015;3:15-9.

Chapleau CA, Lane J, Kirwin SM, Schanen C, Vinette K, Stubbolo D, et al. Detection of rarely identified multiple mutations in MECP2 gene do not contribute to enhanced severity in rett syndrome. American Journal of Medical Genetics Part A. 2013;161(7):1638-46.

Topcu M, Akyerli C, Sayi A, Toruner GA, Kocoglu SR, Cimbis M, et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. European Journal of Human Genetics. 2002;10(1):77-81.

Raizis AM, Saleem M, MacKay R, George PM. Spectrum of MECP2 mutations in New Zealand Rett syndrome patients. The New Zealand Medical Journal (Online). 2009;122(1296).

Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Human molecular genetics. 2000;9(7):1119-29.

Xiang F, Buervenich S, Nicolao P, Bailey ME, Zhang Z, Anvret M. Mutation screening in Rett syndrome patients. Journal of medical genetics. 2000;37(4):250-5.

Hazan F. Genetic approach to the patient and the family: A Rett Syndrome case with p. R270X mutation in MECP2 gene. Türk Biyokimya Dergisi [Turkish Journal of Biochemistry–Turk J Biochem]. 2013;38(1):109-13.

Ellaway CJ, Ho G, Bettella E, Knapman A, Collins F, Hackett A, et al. 14q12 microdeletions excluding FOXG1 give rise to a congenital variant Rett syndrome-like phenotype. European Journal of Human Genetics. 2013;21(5):522-7.

Dragich J, Houwink-Manville I, Schanen C. Rett syndrome: a surprising result of mutation in MECP2. Human molecular genetics. 2000;9(16):2365-75.

Giunti L, Pelagatti S, Lazzerini V, Guarducci S, Lapi E, Coviello S, et al. Spectrum and distribution of MECP2 mutations in 64 Italian Rett syndrome girls: tentative genotype/phenotype correlation. Brain and Development. 2001;23:S242-S5.



  • There are currently no refbacks.

Copyright (c) 2019 Iranian Journal of Child Neurology